VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ventripoint Diagnostics has announced its plan to issue common shares to satisfy interest payments on its convertible debentures, pending approval from the TSXV. Additionally, the company has revised the terms of its convertible debenture offering, adjusting conversion rates over the term’s duration.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.